Please login to the form below

Not currently logged in
Email:
Password:

Algeta execs join Targovax

Anna-Kirsti Aksnes and Tina Madsen join the firm

Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.

Anna-Kirsti Aksnes joins the cancer immunotherapy specialist as VP clinical development and Tina Madsen joins as VP quality assurance.

Aksnes was most recently VP clinical research at Algeta, which was taken over by pharma giant Bayer in 2014. In her role she helped lead strategic, scientific, clinical development and medical communications for the company.

Madsen joins as VP quality assurance, joining from the position of director of product quality assurance. She has over 20 years of experience in the life sciences industry.

Commenting on the appointments, Targovax's CEO Gunnar Gardemyr said: “I am pleased to welcome Anne-Kirst and Tina to our team. We look forward to the insight and wealth of experience that they bring to Targovax.”

29th January 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics